Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium carbonate + cholecalciferol (Benham Pharmaceuticals Ltd.)
- Development stage
- Phase 4
- Lead developer
- Benham Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Carben DS is an oral combination supplement containing calcium carbonate (providing elemental calcium) and cholecalciferol (vitamin D3). Developed and marketed by Benham Pharmaceuticals in Bangladesh, it is formulated as a tablet containing 600 mg of elemental calcium and 400 IU of vitamin D3. Calcium is essential for bone mineralization, muscle contraction, nerve transmission, and blood coagulation, while vitamin D3 is a crucial pro-hormone that undergoes hydroxylation in the body to form calcitriol, which enhances intestinal calcium absorption. Carben DS is primarily indicated for the prevention and treatment of calcium and vitamin D deficiencies, and as an adjunct therapy in the management of bone disorders such as osteoporosis, osteomalacia, rickets, and latent tetany.
- Brand names
- Carben DS
- Other names
- Carben DS 600mg+400IUcalcium carbonate + vitamin d3
02
Targets
CaSR (Extracellular calcium-sensing receptor)RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on calcium carbonate + cholecalciferol (Benham Pharmaceuticals Ltd.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium carbonate + cholecalciferol (Benham Pharmaceuticals Ltd.).